US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist
  • 22.415
  • -0.105-0.47%
Trading Apr 23 14:57 ET
338.14MMarket Cap-3627P/E (TTM)

Jasper Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
34.50%68.86M
28.94%17.73M
52.36%19.36M
49.02%17.83M
9.15%13.95M
38.99%51.2M
13.78%13.75M
26.08%12.71M
42.11%11.96M
104.32%12.78M
Selling and administrative expenses
3.06%17.08M
-12.88%3.89M
22.46%4.51M
18.34%4.53M
-9.76%4.14M
45.19%16.57M
30.36%4.47M
27.50%3.69M
17.35%3.83M
150.27%4.59M
-General and administrative expense
3.06%17.08M
-12.88%3.89M
22.46%4.51M
18.34%4.53M
-9.76%4.14M
45.19%16.57M
30.36%4.47M
27.50%3.69M
17.35%3.83M
150.27%4.59M
Research and development costs
49.55%51.79M
49.05%13.84M
64.58%14.85M
63.45%13.3M
19.75%9.81M
36.21%34.63M
7.22%9.28M
25.51%9.02M
57.78%8.14M
85.25%8.19M
Operating profit
-34.50%-68.86M
-28.94%-17.73M
-52.36%-19.36M
-49.02%-17.83M
-9.15%-13.95M
-38.99%-51.2M
-13.78%-13.75M
-26.08%-12.71M
-42.11%-11.96M
-104.32%-12.78M
Net non-operating interest income expense
641.65%5.2M
254.60%1.23M
453.28%1.43M
1,460.87%1.44M
54,700.00%1.1M
701K
348K
2,977.78%259K
92K
2K
Non-operating interest income
641.65%5.2M
254.60%1.23M
453.28%1.43M
1,460.87%1.44M
54,700.00%1.1M
--701K
--348K
--259K
--92K
--2K
Other net income (expense)
-106.27%-803K
-147.87%-90K
-34.30%385K
-78.80%311K
-113.33%-1.41M
106.75%12.81M
-93.78%188K
-91.22%586K
36,575.00%1.47M
401.97%10.57M
Gain on sale of security
-107.99%-575K
--0
----
----
-109.50%-575K
339.92%7.2M
200.00%150K
-65.56%155K
--845K
272.81%6.05M
Special income (charges)
-99.69%18K
-67.06%28K
-20.85%334K
-32.80%420K
-116.63%-764K
-38.29%5.73M
-97.21%85K
-93.22%422K
--625K
--4.59M
-Less：Restructuring and merger&acquisition
99.69%-18K
67.06%-28K
20.85%-334K
32.80%-420K
116.63%764K
38.29%-5.73M
97.21%-85K
93.22%-422K
---625K
---4.59M
Other non- operating income (expenses)
-113.91%-246K
-151.06%-118K
466.67%51K
-3,533.33%-109K
5.41%-70K
-43.75%-115K
---47K
--9K
-175.00%-3K
-7,500.00%-74K
Income before tax
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.4M
77.37%-2.21M
Income tax
Net income
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.4M
77.37%-2.21M
Net income continuous Operations
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.4M
77.37%-2.21M
Minority interest income
Net income attributable to the parent company
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.4M
77.37%-2.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-71.06%-64.47M
-25.51%-16.58M
-47.89%-17.54M
-54.56%-16.08M
-546.13%-14.26M
-23.00%-37.69M
-45.87%-13.21M
-247.68%-11.86M
-23.65%-10.4M
77.37%-2.21M
Basic earnings per share
40.17%-61.8
58.74%-1.4852
50.00%-1.6
48.28%-1.5
-166.67%-1.6
-284.01%-103.3
-50.47%-3.6
53.62%-3.2
-30.34%-2.9
76.74%-0.6
Diluted earnings per share
40.17%-61.8
58.74%-1.4852
50.00%-1.6
48.28%-1.5
-166.67%-1.6
-284.01%-103.3
-50.47%-3.6
53.62%-3.2
-30.34%-2.9
76.74%-0.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 34.50%68.86M28.94%17.73M52.36%19.36M49.02%17.83M9.15%13.95M38.99%51.2M13.78%13.75M26.08%12.71M42.11%11.96M104.32%12.78M
Selling and administrative expenses 3.06%17.08M-12.88%3.89M22.46%4.51M18.34%4.53M-9.76%4.14M45.19%16.57M30.36%4.47M27.50%3.69M17.35%3.83M150.27%4.59M
-General and administrative expense 3.06%17.08M-12.88%3.89M22.46%4.51M18.34%4.53M-9.76%4.14M45.19%16.57M30.36%4.47M27.50%3.69M17.35%3.83M150.27%4.59M
Research and development costs 49.55%51.79M49.05%13.84M64.58%14.85M63.45%13.3M19.75%9.81M36.21%34.63M7.22%9.28M25.51%9.02M57.78%8.14M85.25%8.19M
Operating profit -34.50%-68.86M-28.94%-17.73M-52.36%-19.36M-49.02%-17.83M-9.15%-13.95M-38.99%-51.2M-13.78%-13.75M-26.08%-12.71M-42.11%-11.96M-104.32%-12.78M
Net non-operating interest income expense 641.65%5.2M254.60%1.23M453.28%1.43M1,460.87%1.44M54,700.00%1.1M701K348K2,977.78%259K92K2K
Non-operating interest income 641.65%5.2M254.60%1.23M453.28%1.43M1,460.87%1.44M54,700.00%1.1M--701K--348K--259K--92K--2K
Other net income (expense) -106.27%-803K-147.87%-90K-34.30%385K-78.80%311K-113.33%-1.41M106.75%12.81M-93.78%188K-91.22%586K36,575.00%1.47M401.97%10.57M
Gain on sale of security -107.99%-575K--0---------109.50%-575K339.92%7.2M200.00%150K-65.56%155K--845K272.81%6.05M
Special income (charges) -99.69%18K-67.06%28K-20.85%334K-32.80%420K-116.63%-764K-38.29%5.73M-97.21%85K-93.22%422K--625K--4.59M
-Less：Restructuring and merger&acquisition 99.69%-18K67.06%-28K20.85%-334K32.80%-420K116.63%764K38.29%-5.73M97.21%-85K93.22%-422K---625K---4.59M
Other non- operating income (expenses) -113.91%-246K-151.06%-118K466.67%51K-3,533.33%-109K5.41%-70K-43.75%-115K---47K--9K-175.00%-3K-7,500.00%-74K
Income before tax -71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M-23.65%-10.4M77.37%-2.21M
Income tax
Net income -71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M-23.65%-10.4M77.37%-2.21M
Net income continuous Operations -71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M-23.65%-10.4M77.37%-2.21M
Minority interest income
Net income attributable to the parent company -71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M-23.65%-10.4M77.37%-2.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -71.06%-64.47M-25.51%-16.58M-47.89%-17.54M-54.56%-16.08M-546.13%-14.26M-23.00%-37.69M-45.87%-13.21M-247.68%-11.86M-23.65%-10.4M77.37%-2.21M
Basic earnings per share 40.17%-61.858.74%-1.485250.00%-1.648.28%-1.5-166.67%-1.6-284.01%-103.3-50.47%-3.653.62%-3.2-30.34%-2.976.74%-0.6
Diluted earnings per share 40.17%-61.858.74%-1.485250.00%-1.648.28%-1.5-166.67%-1.6-284.01%-103.3-50.47%-3.653.62%-3.2-30.34%-2.976.74%-0.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg